In-solution enrichment identifies peptide inhibitors of protein–protein interactions

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Lyubomir T. Vassilev, Binh Thanh Vu, Bradford Graves et al. · Science · 2004 · 4.7K citations

Medicine, Oncology, Pharmacology +15

A new type of synthetic peptide library for identifying ligand-binding activity

Kit S. Lam, Sydney E. Salmon, Evan M. Hersh et al. · Nature · 1991 · 1.8K citations

Pharmacy, Biochemistry, Medicinal Chemistry +16

Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

Yong S. Chang, Bradford Graves, Vincent Guerlavais et al. · Proceedings of the National Academy of Sciences · 2013 · 661 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

A Perfluoroaryl-Cysteine S _N Ar Chemistry Approach to Unprotected Peptide Stapling

Alexander M. Spokoyny, Yekui Zou, Jingjing Ling et al. · Journal of the American Chemical Society · 2013 · 465 citations

Life Sciences, Biochemistry, Medicinal Chemistry +17

Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX

Marzena Pazgier, Min Liu, Guozhang Zou et al. · Proceedings of the National Academy of Sciences · 2009 · 386 citations · Full text

Medicine, Molecular Biology, Oncology +15